Your Source for Venture Capital and Private Equity Financings

Massinvestor/VC News Daily

VC-funded Company:

Werewolf Therapeutics
1030 Massachusetts Avenue, Suite 210
Cambridge, MA 02138
Phone: 617-952-0555

Werewolf Therapeutics is an oncology biotherapeutics company advancing a pipeline of next-generation, transformative cancer treatments designed to focus the body's immune response to selectively target cancer. Werewolf's proprietary PREDATOR™ protein engineering platform combines a variety of approaches to actively silence the drug while in systemic circulation, optimize its pharmacokinetic profile, and rapidly and efficiently transform into the fully active state upon reaching the tumor microenvironment for maximum therapeutic potential. Werewolf is creating a new era of tumor-selective, systemically delivered drugs with the potential to deliver more effective, less toxic treatments for people with cancer.

Key Contact
Dan Hicklin
Funding Events

11/20/19 $56,000,000 Series A Arkin Bio Ventures
DC Investment Partners
Longwood Fund
MPM Capital
Taiho Ventures
UPMC Enterprises